DMPHF OTC
Dermapharm Holding SE
1W: +0.0%
1M: +0.0%
3M: -10.0%
YTD: +20.6%
1Y: +20.6%
3Y: +17.4%
$47.69
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$201M
-8.2% ▼
5Y CAGR: +14.9%
Capital Expenditures
$38M
+8.0% ▲
5Y CAGR: -3.8%
Free Cash Flow
$163M
-8.3% ▼
5Y CAGR: +24.7%
Dividends Paid
$47M
+16.2% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$37M
-586.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $125M | $293M | $216M | $62M | $172M |
| Depreciation & Amort. | $47M | $55M | $95M | $102M | $87M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$14M | -$46M | -$4M | $9M | -$18M |
| Other Non-Cash Items | -$28M | -$51M | -$19M | $46M | -$39M |
| Operating Cash Flow | $131M | $250M | $289M | $219M | $201M |
| — Investing Activities — | |||||
| Capital Expenditures | -$41M | -$61M | -$39M | -$42M | -$38M |
| Acquisitions (Net) | -$69M | -$23M | -$70M | -$389M | $0 |
| Investment Purchases | $0 | -$48M | -$6M | $0 | -$404K |
| Investment Sales | $0 | $61M | $10M | $8M | $707K |
| Other Investing | $4M | -$59M | $6M | $8M | $8M |
| Investing Cash Flow | -$106M | -$129M | -$99M | -$415M | -$30M |
| — Financing Activities — | |||||
| Net Debt Issuance | $56M | -$26M | -$71M | $301M | -$101M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$43M | -$47M | -$117M | -$57M | -$47M |
| Other Financing | -$27M | -$8M | -$12M | -$40M | -$60M |
| Financing Cash Flow | -$14M | -$81M | -$200M | $205M | -$209M |
| Net Change in Cash | $11M | $41M | -$10M | $8M | -$37M |
| Cash End of Period | $120M | $161M | $151M | $159M | $121M |
| Free Cash Flow | $90M | $189M | $250M | $178M | $163M |